The use of erythropoietin in a Jehovah's Witness undergoing major surgery and chemotherapy
Open Access
- 1 March 1991
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 63 (3) , 476
- https://doi.org/10.1038/bjc.1991.111
Abstract
No abstract availableKeywords
This publication has 3 references indexed in Scilit:
- Benefits and risks of protracted treatment with human recombinant erythropoietin in patients having haemodialysis.BMJ, 1987
- Correction of the Anemia of End-Stage Renal Disease with Recombinant Human ErythropoietinNew England Journal of Medicine, 1987
- EFFECT OF HUMAN ERYTHROPOIETIN DERIVED FROM RECOMBINANT DNA ON THE ANAEMIA OF PATIENTS MAINTAINED BY CHRONIC HAEMODIALYSISThe Lancet, 1986